Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Texan Professor .......2015
View:
Post by cheetio on Jul 08, 2015 1:52am

Texan Professor .......2015

mcna......what's that..... https://gucasym.org/alternatives-bcg-immunotherapy-bladder-cancer-treatment-during-drug-shortages
Comment by simouuun on Jul 08, 2015 8:34am
It's a shame that you only think about the financial performance for investors of TST.  You wish TST all the worst. You don't seem to see the opportunity for ill people, who suffer from bladder-cancer. They build hopes in new drugs! MCNA could be their hope - Clinical trial data indicates that it can be a good drug for them! That's fact... So better hope the suffering people will ...more  
Comment by cheetio on Jul 08, 2015 8:41pm
You don't seem to see the opportunity for ill people, who suffer from bladder-cancer...............Guess all those bladder expert boys need glasses hey....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities